Category: Angle

  • Angle claims FDA okay for Parsortix liquid biopsy system

    After more than six years of development, Angle has scored an FDA approval for Parsortix as a diagnostic for metastatic breast cancer – the first ever in the US for a device used to detect cancer by harvesting cells from a patient blood sample. In a statement, the UK medical device firm said its “liquid […]